XANAX cpr 0.25 mg 30 pce
7680432160157
CH-43216
N05BA12
01.04.1.
Reimbursement limitations:
120PISL
Prescription limitée au maximum à 120 points. Iniectabilia sine limitatione
1 / 2
google
Details
- Product number
- 4321601
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- alprazolamum 0.25 mg, lactosum monohydricum 96 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, natrii docusas, silica colloidalis anhydrica, E 211 0.11 mg pro compresso corresp. natrium 0.051 mg.
Articles (1)
Xanax 0,25 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
96.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.11 MG | Substance | HBESI |
|
(N/A)
|
0.051 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 10.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1982
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 43216
- Drug name
- Xanax, Tabletten
- Galenic form
- TAB
- ATC Code
- N05BA12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/10/1980
- Authorization expiration date
- 31/12/9999
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XANAX cpr 0.25 mg 30 pce
- Description (DE)
- XANAX Tabl 0.25 mg 30 Stk
- Market launch
- 21/10/1980
- Narcotic (BTM)
- B